Mårten Fernö

Researcher
More filtering options
  1. 2013
  2. The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer.

    Klintman, M., Carina Forsare, Ahlin, C., Beglerbegovic, S., Fjällskog, M-L., Grabau, D., Gudlaugsson, E., Janssen, E. A. M., Lövgren, K., Skaland, I., Pär-Ola Bendahl, Per Malmström, Baak, J. P. A. & Mårten Fernö, 2013, In : PLoS ONE. 8, 12, e81902.

    Research output: Contribution to journalArticle

  3. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

    Alkner, S., Bendahl, P., Grabau, D., Per Malmström, Mårten Fernö & Lisa Rydén, 2013, In : Annals of Oncology. 24, 5, p. 1244-1252

    Research output: Contribution to journalArticle

  4. 2012
  5. A Molecular Taxonomy for Urothelial Carcinoma.

    Gottfrid Sjödahl, Martin Lauss, Lövgren, K., Chebil, G., Gudjonsson, S., Veerla, S., Oliver Hultman Patschan, Mattias Aine, Mårten Fernö, Markus Ringnér, Wiking Månsson, Fredrik Liedberg, David Lindgren & Mattias Höglund, 2012, In : Clinical Cancer Research. 18, 12, p. 3377-3386

    Research output: Contribution to journalArticle

  6. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study

    Falck, A-K., Pär-Ola Bendahl, Christian Ingvar, Isola, J., Jönsson, P-E., Lindblom, P., Lövgren, K., Rennstam, K., Mårten Fernö & Lisa Rydén, 2012, In : BMC Cancer. 12

    Research output: Contribution to journalArticle

  7. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.

    Karolina Holm, Grabau, D., Lövgren, K., Aradottir, S., Sofia Gruvberger, Jillian Howlin, Lao Saal, Ethier, S. P., Pär-Ola Bendahl, Stål, O., Per Malmström, Mårten Fernö, Lisa Rydén, Cecilia Hegardt, Åke Borg & Markus Ringnér, 2012, In : Molecular Oncology. 6, 5, p. 494-506

    Research output: Contribution to journalArticle

  8. Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial

    Hatschek, T., Carlsson, L., Einbeigi, Z., Lidbrink, E., Linderholm, B., Lindh, B., Niklas Loman, Malmberg, M., Rotstein, S., Soderberg, M., Sundquist, M., Walz, T. M., Hellstrom, M., Svensson, H., Astrom, G., Brandberg, Y., Carstensen, J., Mårten Fernö & Bergh, J., 2012, In : Breast Cancer Research and Treatment. 131, 3, p. 939-947

    Research output: Contribution to journalArticle

  9. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.

    Jönsson, G. B., Staaf, J., Vallon-Christersson, J., Ringnér, M., Gruvberger, S., Saal, L., Holm, K., Hegardt, C., Arason, A., Fagerholm, R., Olsson, C., Grabau, D., Johnsson, E., Lövgren, K., Magnusson, L., Heikkilä, P., Agnarsson, B. A., Johannsson, O. T., Malmström, P., Fernö, M. & 5 othersHåkan Olsson, Niklas Loman, Nevanlinna, H., Barkardottir, R. B. & Åke Borg, 2012, In : Cancer Research. 72, 16, p. 4028-4036

    Research output: Contribution to journalArticle

  10. 2011
  11. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.

    Carlsson, M., Cederfur, C., Schaar, V., Balog, C. I. A., Lepur, A., Touret, F., Salomonsson, E., Deelder, A. M., Mårten Fernö, Håkan Olsson, Wuhrer, M. & Hakon Leffler, 2011, In : PLoS ONE. 6, 10, e26560.

    Research output: Contribution to journalArticle

  12. Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

    Carlsson, A., Christer Wingren, Nordström, M., Carsten Rose, Mårten Fernö, Håkan Olsson, Jernstöm, H., Sara Ek, Gustavsson, E., Christian Ingvar, Mattias Ohlsson, Peterson, C. & Carl Borrebaeck, 2011, In : Proceedings of the National Academy of Sciences. 108, 34, p. 14252-14257

    Research output: Contribution to journalArticle

  13. 2010
  14. AIB1 is a predictive factor for tamoxifen response in premenopausal women.

    Alkner, S., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Stål, O., Lisa Rydén & Mårten Fernö, 2010, In : Annals of Oncology. 21, p. 238-244

    Research output: Contribution to journalArticle

  15. Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.

    Klintman, M., Ornbjerg Würtz, S., Christensen, I., Bræmer Hertel, P., Mårten Fernö, Malmberg, M., Mouridsen, H., Cold, F., Schrohl, A-S., Foekens, J., Per Malmström & Brünner, N., 2010, In : Breast Cancer Research and Treatment. 121, p. 365-371

    Research output: Contribution to journalArticle

  16. Cyclin A - an alternative to gene expression profiling for subdividing histological grade 2 breast cancer into groups with different prognosis

    Carina Forsare, AhlinGullers, A., Fjallskog, M. L., Malmstrom, P. & Mårten Fernö, 2010, In : EJC Supplements. 8, 3, p. 95-96

    Research output: Contribution to journalPublished meeting abstract

  17. Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort.

    Emma Niméus, Koliadi, A., Ahlin, C., Holmqvist, M., Holmberg, L., Amini, R-M., Karin Jirström, Wärnberg, F., Blomqvist, C., Mårten Fernö & Fjällskog, M-L., 2010, In : International Journal of Cancer. 127, p. 961-967

    Research output: Contribution to journalArticle

  18. Ki-67 as a long-term prognostic factor in lobular breast cancer

    Ulrik Narbe, Pär-Ola Bendahl, Grabau, D., Lisa Rydén, Mårten Fernö & Christian Ingvar, 2010, In : EJC Supplements. 8, 3, p. 98-98

    Research output: Contribution to journalPublished meeting abstract

  19. Nuclear Janus-Activated Kinase 2/Nuclear Factor 1-C2 Suppresses Tumorigenesis and Epithelial-to-Mesenchymal Transition by Repressing Forkhead Box F1.

    Nilsson, J., Helou, K., Kovács, A., Pär-Ola Bendahl, Bjursell, G., Mårten Fernö, Carlsson, P. & Kannius-Janson, M., 2010, In : Cancer Research. 70, p. 2020-2029

    Research output: Contribution to journalArticle

  20. 2009
  21. Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort

    Emma Niméus, Koliadi, A., Ahlin, C., Holmqvist, M., Holmberg, L., Amini, R-M., Jirstrom, K., Warnberg, F., Blomqvist, C., Mårten Fernö & Fjallskog, M-L., 2009, In : Cancer Research. 69, 24, p. 839S-839S

    Research output: Contribution to journalPublished meeting abstract

  22. Is the prognostic value of Ki-67 dependent on ER status and histological grade?

    Klintman, M., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Per Malmström & Mårten Fernö, 2009, In : Cancer Research. 69, 2, p. 128S-128S

    Research output: Contribution to journalPublished meeting abstract

  23. Significantly higher expression of vascular endothelial growth factor (VEGF) and shorter survival after recurrences in premenopausal node negative patients with triple negative breast cancer

    Linderholm, B. K., Klintman, M., Grabau, D., Pär-Ola Bendahl, Mårten Fernö & Per, M., 2009, In : Cancer Research. 69, 2, p. 128S-129S

    Research output: Contribution to journalPublished meeting abstract

  24. Validation of the predictive value of tissue inhibitor of metalloproteinases-1 for the response to first-line chemotherapy in metastatic breast cancer.

    Wuertz, S. O., Klintman, M., Christensen, I. J., Hertel, P. B., Mårten Fernö, Malmberg, M., Mouridsen, H., Cold, F., Schrohl, A-S., Foekens, J. A., Per Malmström & Brunner, N., 2009, In : Cancer Research. 69, 2, p. 363S-364S

    Research output: Contribution to journalPublished meeting abstract

  25. 2008
  26. Analys av HER2 i bröstcancer kvalitetssäkrad. Viktig behandlingsprediktiv och prognostisk faktor.

    Mårten Fernö, Haglund, M., Pär-Ola Bendahl, Olsson, H. & Lisa Rydén, 2008, In : Läkartidningen. 105, 32-33, p. 2181-2184

    Research output: Contribution to journalArticle

  27. Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.

    Berglund, P., Stighall, M., Karin Jirström, Rydén, L., Mårten Fernö, Nordenskjold, B. & Landberg, G., 2008, In : Journal of Clinical Pathology. 61, p. 184-191

    Research output: Contribution to journalArticle

  28. Exploring the two-gene ratio in breast cancer-independent roles for HOXB13 and IL17BR in prediction of clinical outcome

    Jerevall, P-L., Brommesson, S., Carina Forsare, Sofia Gruvberger, Per Malmström, Nordenskjöld, B., Wingren, S., Söderkvist, P., Mårten Fernö & Stål, O., 2008, In : Breast Cancer Research and Treatment. 107, 2, p. 225-234

    Research output: Contribution to journalArticle

  29. Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast conservation surgery with or without postoperative radiotherapy

    Emma Niméus, Krogh, M., Per Malmström, Carina Forsare, Fredriksson, I., Karlsson, P., Nordenskjöld, B., Stål, O., Östberg, G., Peterson, C. & Mårten Fernö, 2008, In : Breast Cancer Research. 10, 2

    Research output: Contribution to journalArticle

  30. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.

    Carlsson, A., Christer Wingren, Ingvarsson, J., Ellmark, P., Bo Baldetorp, Mårten Fernö, Håkan Olsson & Carl Borrebaeck, 2008, In : European Journal of Cancer. 44, 3, p. 472-480

    Research output: Contribution to journalArticle